Home / Stocks / BOLT

BOLT insider trading

Bolt Biotherapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$8k
Buys · last 90 days
0 · $0
Most recent buy
2026-02-04

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-02-04Quinn William P.
President, CEO and CFO
Bought125$4.61$576
2026-02-04Nemec Sarah
Senior VP, Finance and PAO
Bought125$4.61$576
2025-10-24Nemec Sarah
Senior VP, Finance and PAO
Bought125$5.49$686
2025-10-24Quinn William P.
President, CEO and CFO
Bought125$5.49$686
2025-05-05Nemec Sarah
Senior VP, Finance and PAO
Bought5,000$0.57$3k
2025-05-05Quinn William P.
President, CEO and CFO
Bought5,000$0.57$3k

Most active insider buyers

InsiderRoleBuysTotal bought
Quinn William P.President, CEO and CFO3$4k
Nemec SarahSenior VP, Finance and PAO3$4k

See BOLT on the chart

Every insider buy and sell for BOLT plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.